• Retrouvez les faits marquants de VIDAL dans nos communiqués de presse.

    Find out more about VIDAL in our press releases.

Press releases


VIDAL Sentinel integrates the service of the startup ExactCure

VIDAL Sentinel, a tool for analyzing the risk of hospital prescriptions, integrates the service of the startup ExactCure, specializing in personalized drug simulation

Download the press release


MonEcho (logo)

VIDAL Group acquired MonEcho.

With this acquisition, VIDAL Group strengthens the position of WEDA, a software publisher of online patient records for independent healthcare professionals. It will enable its customers to benefit from a digital management service for ultrasound consultations, aimed in particular at obstetricians, midwives, cardiologists and any healthcare professional using ultrasound.

Download the press release


Weda (logo)

VIDAL acquires WEDA and strengthens its service offering for healthcare professionals.

WEDA, the leader in online patient record software, offers a complete solution for self-employed healthcare professionals working individually, in group practices or in multidisciplinary health centers. The WEDA platform currently has more than 10,000 users, 60% of whom are doctors.

Dowload the press release


Groupe CEGI (logo)

VIDAL and CEGI, a successful partnership.

With the launch of its NeXT range, CEGI worked closely with its partner VIDAL to optimize the integration of the data offered by its drug repository. The objective was to maximize the scientific value added by VIDAL and to offer an intuitive and fluid user interface, which is the foundation of the NeXT approach.

Download the press release


Health Data Hub (logo)

The PINPOM project presented by VIDAL, selected among the winners of the first call for projects of the Health Data Hub.

Agnès Buzyn, Minister of Solidarity and Health, announced on April 16, 2019 the list of the ten winners of the first call for projects of the Health Data Hub. The PIMPON Project (Prioritization of Medicinal Interactions by their Clinical PONderation), presented by VIDAL, is one of them, chosen by a jury of experts from 189 submissions.

Download the press release


EurekaSanté 10e anniversaire

EurekaSante.fr : 10 years of protection against fake news in health.

Tired of misinformation in health care? Lost in contradictory information on the treatment or prevention of diseases? EurekaSante.fr, VIDAL's public website, is celebrating its 10th anniversary. Ten years of health information based on the recommendations of public health authorities and learned societies. In case of doubt, EurekaSante.fr remains THE source of information and easy to understand on all aspects of health.

Download the press release


VIDAL Parcours de soins - e-formations

VIDAL launches into e-learning with Parcours de soins.

VIDAL's mission has always been to inform and support healthcare professionals with a view to continuously improving therapeutic management.

Today, as part of their professional training, doctors are increasingly turning to the Internet and online digital solutions to update their knowledge. Saving time and a real desire to remain an active participant in their training are the main reasons for their choice.

In order to understand physicians' expectations in terms of medical training, VIDAL conducted its own survey in March 2018 among 393 practitioners (general practitioners and hospitalists).

Download the press release


Médicosport-santé

Médicosport-santé, launch of a digital version in partnership with VIDAL.

The French National Olympic and Sports Committee (CNOSF), launched this Monday, December 3, 2018, in partnership with VIDAL, the digital version of Médicosport-santé. The Médicosport-santé is a dictionary with a medical purpose of sports disciplines that lists the physical, physiological and mental characteristics of each sport discipline as well as the conditions of practice in the context of sport-health (primary, secondary and tertiary prevention). To date, 45 sports federations have joined the system.

Download the press release


VIDAL Group M3

Acquisition of VIDAL Group by M3.

VIDAL Group, a drug information specialist, announces a draft agreement providing for the acquisition of the entire group by the Japanese company M3 for approximately €100 million. This draft agreement is expected to be finalized by the end of 2016. M3 is a leader in the medical information and new technologies sector in Japan, the US and worldwide. A leader in the field of healthcare product databases, VIDAL Group has led a complete transition to digital in recent years to become a key player in medical information in France and Europe.

Download the press release